Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034378839> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2034378839 endingPage "494" @default.
- W2034378839 startingPage "486" @default.
- W2034378839 abstract "El término síndrome de dolor regional complejo de las extremidades aparece para esclarecer las anteriores entidades denominadas distrofia simpaticorrefleja y causalgia. Su diagnóstico sigue siendo difícil a pesar de los esfuerzos de la Asociación Internacional para el Estudio del Dolor para diferenciar ambas entidades. De manera característica el síntoma predominante es el dolor neuropático cuya respuesta a los fármacos analgésicos actuales es en general mala. Entre los fármacos de uso frecuente para tratar este síndrome se encuentran los glucocorticoides, cuya eficacia no está totalmente demostrada y presentan efectos secundarios importantes que impiden su utilización en pacientes con otras patologías concomitantes. Los fármacos opioides tienen un manejo difícil por los efectos secundarios, precisando un control estricto por parte del médico. El uso de antidepresivos tricíclicos buscando su efecto analgésico presenta también importantes efectos secundarios que pueden poner en peligro la vida del paciente, sobre todo si es cardiópata. Del heterogéneo grupo de fármacos anticonvulsivantes es gabapentina el que parece ofrecer una importante mejora de la calidad de vida de estos pacientes y un perfil de seguridad que hacen que sea considerada como el tratamiento de elección. The term complex regional painful syndrome of the limbs seeks to clarify previous entities known as sympathicoreflex dystrophia and causalgia. Its diagnosis continues to be difficult despite the International Association for the Study of the Pain efforts for distinguish both entities. The predominant symptom is characteristically the neuropathic pain whose response to the current analgesic drugs is generally poor. Glucocorticoids are among the most frequent used drugs in the treatment of this syndrome; their effectiveness is, however, not entirely demonstrated and they give rise to important side effects that impede their use in patients with other concomitant conditions. Opioids are difficult to manage because of their side effects which require a strict control by the physician. The use of tricyclic antidepressants because of its analgesic effect is also associated to severe side effects that can be potentially lethal in patients with cardiopathy. In the heterogeneous group of anticonvulsant drugs gabapentin is regarded the treatment of choice because it seems to provide a high improvement of the quality of life in these patients besides a good safety profile." @default.
- W2034378839 created "2016-06-24" @default.
- W2034378839 creator A5010424627 @default.
- W2034378839 creator A5035933106 @default.
- W2034378839 creator A5048062755 @default.
- W2034378839 date "2004-01-01" @default.
- W2034378839 modified "2023-10-17" @default.
- W2034378839 title "Tratamiento farmacológico del síndrome doloroso regional complejo de las extremidades como causa de dolor neuropático" @default.
- W2034378839 cites W1511198581 @default.
- W2034378839 cites W1541229271 @default.
- W2034378839 cites W165161983 @default.
- W2034378839 cites W1965693537 @default.
- W2034378839 cites W1972807197 @default.
- W2034378839 cites W1972813992 @default.
- W2034378839 cites W1982022301 @default.
- W2034378839 cites W1995856060 @default.
- W2034378839 cites W2001190920 @default.
- W2034378839 cites W2092872784 @default.
- W2034378839 cites W2102368782 @default.
- W2034378839 cites W2103496686 @default.
- W2034378839 cites W2112852016 @default.
- W2034378839 cites W2120795124 @default.
- W2034378839 cites W2142775840 @default.
- W2034378839 cites W2145260111 @default.
- W2034378839 cites W2177410815 @default.
- W2034378839 cites W21829949 @default.
- W2034378839 cites W2419603523 @default.
- W2034378839 cites W59036416 @default.
- W2034378839 cites W87452813 @default.
- W2034378839 cites W93483261 @default.
- W2034378839 doi "https://doi.org/10.1016/s0014-2565(04)71522-2" @default.
- W2034378839 hasPublicationYear "2004" @default.
- W2034378839 type Work @default.
- W2034378839 sameAs 2034378839 @default.
- W2034378839 citedByCount "3" @default.
- W2034378839 countsByYear W20343788392012 @default.
- W2034378839 crossrefType "journal-article" @default.
- W2034378839 hasAuthorship W2034378839A5010424627 @default.
- W2034378839 hasAuthorship W2034378839A5035933106 @default.
- W2034378839 hasAuthorship W2034378839A5048062755 @default.
- W2034378839 hasConcept C138885662 @default.
- W2034378839 hasConcept C15708023 @default.
- W2034378839 hasConcept C29456083 @default.
- W2034378839 hasConcept C71924100 @default.
- W2034378839 hasConceptScore W2034378839C138885662 @default.
- W2034378839 hasConceptScore W2034378839C15708023 @default.
- W2034378839 hasConceptScore W2034378839C29456083 @default.
- W2034378839 hasConceptScore W2034378839C71924100 @default.
- W2034378839 hasIssue "9" @default.
- W2034378839 hasLocation W20343788391 @default.
- W2034378839 hasOpenAccess W2034378839 @default.
- W2034378839 hasPrimaryLocation W20343788391 @default.
- W2034378839 hasRelatedWork W1506200166 @default.
- W2034378839 hasRelatedWork W1995515455 @default.
- W2034378839 hasRelatedWork W1999344589 @default.
- W2034378839 hasRelatedWork W2039318446 @default.
- W2034378839 hasRelatedWork W2080531066 @default.
- W2034378839 hasRelatedWork W2748952813 @default.
- W2034378839 hasRelatedWork W2789448498 @default.
- W2034378839 hasRelatedWork W2899084033 @default.
- W2034378839 hasRelatedWork W3032375762 @default.
- W2034378839 hasRelatedWork W3108674512 @default.
- W2034378839 hasVolume "204" @default.
- W2034378839 isParatext "false" @default.
- W2034378839 isRetracted "false" @default.
- W2034378839 magId "2034378839" @default.
- W2034378839 workType "article" @default.